期刊文献+

Activity after Site-Directed Mutagenesis of CD59 on Complement-Mediated Cytolysis 被引量:8

Activity after Site-Directed Mutagenesis of CD59 on Complement-Mediated Cytolysis
原文传递
导出
摘要 CD59 may inhibit the cytolytic activity of complement by binding to C8/C9 and protect host cell membranes against homologous membrane attack complex (MAC). However, CD59 is widely overexpressed on tumor cells, which has been implicated in tumorigenesis. The active site of CD59 relative to MAC is still confused. As reported the MAC binding site is located in the vicinity of a hydrophobic groove on the membrane distal face of the protein centered around residue W40. Here two site-directed mutagenesis were performed by overlapping extension PCR to delete residue W40 site (Mutant 1, M1) or to change C39W40K41 to W39W40W41 (Mutant 2, M2). Then we constructed mutant CD59 eukaryotic expression system and investigated their biological function on CI-IO cells compared with wild-type CD59. Stable populations of CHO cells expressing recombinant proteins were screened by immunotechnique. After 30 passages culturing, proteins could be tested. Dye release assays suggest that M1CD59 loses the activity against complement, while M2CD59 increases the anti-complement activity slightly. Results indicate that W40 of human CD59 is important to its activity, and prohibition of this site may be a potential way to increase complement activity and to treat tumors. Cellular & Molecular Immunology. CD59 may inhibit the cytolytic activity of complement by binding to C8/C9 and protect host cell membranes against homologous membrane attack complex (MAC). However, CD59 is widely overexpressed on tumor cells, which has been implicated in tumorigenesis. The active site of CD59 relative to MAC is still confused. As reported the MAC binding site is located in the vicinity of a hydrophobic groove on the membrane distal face of the protein centered around residue W40. Here two site-directed mutagenesis were performed by overlapping extension PCR to delete residue W40 site (Mutant 1, M1) or to change C39W40K41 to W39W40W41 (Mutant 2, M2). Then we constructed mutant CD59 eukaryotic expression system and investigated their biological function on CI-IO cells compared with wild-type CD59. Stable populations of CHO cells expressing recombinant proteins were screened by immunotechnique. After 30 passages culturing, proteins could be tested. Dye release assays suggest that M1CD59 loses the activity against complement, while M2CD59 increases the anti-complement activity slightly. Results indicate that W40 of human CD59 is important to its activity, and prohibition of this site may be a potential way to increase complement activity and to treat tumors. Cellular & Molecular Immunology.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2008年第2期141-146,共6页 中国免疫学杂志(英文版)
基金 National Natural Science Foundation of China (No.30671936).
关键词 CD59 COMPLEMENT active site site-directed mutagenesis overlap.extension PCR CD59, complement, active site, site-directed mutagenesis, overlap.extension PCR
  • 相关文献

参考文献2

二级参考文献17

  • 1萨姆布鲁克J 拉塞尔DW 黄培堂译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002..
  • 2Walsh LA, Tone M, Thiru S, et al. The CD59 antigen-αmultifunctional molecule[J]. Tissue Antigens, 1992, 40(5): 213-220.
  • 3Brooimans RA, van Wieringen PA, van Es LA, et al. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis[J]. Eur J Immunol, 1992, 22 (12): 3135-3140.
  • 4Miyagawa S, Shirakura R, Matsumiga G, et al. Possible of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation[J]. Transplant Proc, 1994, 26(3): 1235-1238.
  • 5Juan A, Judith H, Rudolf F, et al. Molecular basis for a link between complement and the vascular complications of diabetes[J]. Proc Natl Acad Sci USA, 2000, 97(10): 5450-5455.
  • 6萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T(金冬雁 译).分子克隆实验指南.第2版[M].北京: 科学出版社,1995.5-57,870-898.
  • 7Bodian DL,Davis SJ,Morgan BP,Rushmere NK.Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein,CD59[J].J Exp Med,1997,185 (3):507-516
  • 8Yu J,Abagyan R,Dong S,Gilbert A,Nussenzweig V,Tomlinson S.Mapping the active site of CD59[J].J Exp Med,1997,185 (4):745-753
  • 9Halperin JA,Taratuska A,Anicholson Weller A.Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cell[J].J Clin Invest,1993,91 (5):1 974-978
  • 10Torzewski J,Oldroyd R,Lachmann P,Fitzsimmons C,Proudfoot D,Bowyer D.Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cell.A possible initiating event in atherosclerotic lesion formation[J].Arterioscler Thromb Vasc Biol,1996,16 (5):673-677

共引文献5

同被引文献19

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部